Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6LF5

The solution structure of ShSPI

6LF5 の概要
エントリーDOI10.2210/pdb6lf5/pdb
分子名称ShSPI (1 entity in total)
機能のキーワードneutrophil elastase inhibitor, toxin
由来する生物種Scolopendra hainanum
タンパク質・核酸の鎖数1
化学式量合計3960.59
構造登録者
Luan, N.,Rong, M.Q.,Liu, J.X.,Lai, R. (登録日: 2019-11-29, 公開日: 2020-12-02, 最終更新日: 2024-10-23)
主引用文献Luan, N.,Zhao, Q.,Duan, Z.,Ji, M.,Xing, M.,Zhu, T.,Mwangi, J.,Rong, M.,Liu, J.,Lai, R.
Identification and Characterization of ShSPI, a Kazal-Type Elastase Inhibitor from the Venom of Scolopendra Hainanum .
Toxins, 11:-, 2019
Cited by
PubMed Abstract: Elastase is a globular glycoprotein and belongs to the chymotrypsin family. It is involved in several inflammatory cascades on the basis of cleaving the important connective tissue protein elastin, and is strictly regulated to a balance by several endogenous inhibitors. When elastase and its inhibitors are out of balance, severe diseases will develop, especially those involved in the cardiopulmonary system. Much attention has been attracted in seeking innovative elastase inhibitors and various advancements have been taken on clinical trials of these inhibitors. Natural functional peptides from venomous animals have been shown to have anti-protease properties. Here, we identified a kazal-type serine protease inhibitor named ShSPI from the cDNA library of the venom glands of . ShSPI showed significant inhibitory effects on porcine pancreatic elastase and human neutrophils elastase with values of 225.83 ± 20 nM and 12.61 ± 2 nM, respectively. Together, our results suggest that ShSPI may be an excellent candidate to develop a drug for cardiopulmonary diseases.
PubMed: 31817486
DOI: 10.3390/toxins11120708
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 6lf5
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon